资源类型:
期刊
WOS体系:
Article
Pubmed体系:
Journal Article;Review
收录情况:
◇ SCIE
文章类型:
论著
单位:
[1]Department of Orthopaedic Surgery,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,China
外科学系
华中科技大学同济医学院附属同济医院
骨科
ISSN:
1043-6618
关键词:
Intervertebral disc degeneration
Metabolic dysfunction
Bioenergetics
Glycolysis
摘要:
Intervertebral disc (IVD) degeneration is a frequent cause of low back pain and is the most common cause of disability. Treatments for symptomatic IVD degeneration, including conservative treatments such as analgesics, physical therapy, anti-inflammatories and surgeries, are aimed at alleviating neurological symptoms. However, there are no effective treatments to prevent or delay IVD degeneration. Previous studies have identified risk factors for IVD degeneration such as aging, inflammation, genetic factors, mechanical overload, nutrient deprivation and smoking, but metabolic dysfunction has not been highlighted. IVDs are the largest avascular structures in the human body and determine the hypoxic and glycolytic features of nucleus pulposus (NP) cells. Accumulating evidence has demonstrated that intracellular metabolic dysfunction is associated with IVD degeneration, but a comprehensive review is lacking. Here, by reviewing the physiological features of IVDs, pathological processes and metabolic changes associated with IVD degeneration and the functions of metabolic genes in IVDs, we highlight that glycolytic pathway and intact mitochondrial function are essential for IVD homeostasis. In degenerated NPs, glycolysis and mitochondrial function are downregulated. Boosting glycolysis such as HIF1α overexpression protects against IVD degeneration. Moreover, the correlations between metabolic diseases such as diabetes, obesity and IVD degeneration and their underlying molecular mechanisms are discussed. Hyperglycemia in diabetic diseases leads to cell senescence, the senescence-associated phenotype (SASP), apoptosis and catabolism of extracellualr matrix in IVDs. Correcting the global metabolic disorders such as insulin or GLP-1 receptor agonist administration is beneficial for diabetes associated IVD degeneration. Overall, we summarized the recent progress of investigations on metabolic contributions to IVD degeneration and provide a new perspective that correcting metabolic dysfunction may be beneficial for treating IVD degeneration.Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.
基金:
We thank the Foundation of Tongji Hospital for the grant (No. 23-
2RSC09004-003) to support this study.
WOS:
WOS:001210086700001
PubmedID:
38417775
中科院(CAS)分区:
出版当年[2023]版:
大类
|
2 区
医学
小类
|
1 区
药学
最新[2025]版:
大类
|
2 区
医学
小类
|
1 区
药学
JCR分区:
出版当年[2022]版:
Q1
PHARMACOLOGY & PHARMACY
最新[2023]版:
Q1
PHARMACOLOGY & PHARMACY
影响因子:
9.1
最新[2023版]
9
最新五年平均
9.3
出版当年[2022版]
8.8
出版当年五年平均
10.334
出版前一年[2021版]
9.1
出版后一年[2023版]
第一作者:
Song Chao
第一作者单位:
[1]Department of Orthopaedic Surgery,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,China
共同第一作者:
Hu Peixuan;Peng Renpeng
通讯作者:
Li Feng;Fang Zhong;Xu Yong
推荐引用方式(GB/T 7714):
Song Chao,Hu Peixuan,Peng Renpeng,et al.Bioenergetic dysfunction in the pathogenesis of intervertebral disc degeneration[J].Pharmacological Research.2024,202:107119.doi:10.1016/j.phrs.2024.107119.
APA:
Song Chao,Hu Peixuan,Peng Renpeng,Li Feng,Fang Zhong&Xu Yong.(2024).Bioenergetic dysfunction in the pathogenesis of intervertebral disc degeneration.Pharmacological Research,202,
MLA:
Song Chao,et al."Bioenergetic dysfunction in the pathogenesis of intervertebral disc degeneration".Pharmacological Research 202.(2024):107119